Eli Lilly has the lead in the GLP-1 race, but Novo Nordisk just changed the game.

Novo’s oral Wegovy launch has intensified competition for Eli Lilly heading into 2026. ・Lilly’s outlook hinges on oral drug ...

Eli Lilly is considering all these risks and planning accordingly, and doing so years in advance. That's also why the ...

In the latest trading session, Eli Lilly (LLY) closed at $1,041.51, marking a -3.6% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.64% for the day.

Shares of Eli Lilly plummeted 14% on Thursday, pacing what would be the stock’s largest loss in decades after the pharmaceutical giant unveiled data for its obesity treatment pill that fell behind ...

Drug maker Eli Lilly’s share price plunged Wednesday morning after the company reported worse third-quarter results than expected, especially in its weight-loss drug division, registering a rare ...

Eli Lilly will cap the out-of-pocket cost of its insulin at $35 a month, the drugmaker said Wednesday. The move, experts say, could prompt other insulin makers in the U.S. to follow suit. The change, ...

Despite Super Bowl rings and big plays, "Manning fatigue" may hurt his case. That would be a shame because Eli was a master ...

(Editor’s note: This story was written before Eli Manning was not included in the Pro Football Hall of Fame class of 2025.) Two guys are sitting in a bar. They could be talking about who the Giants’ ...

It might be Eli Manning’s turn to answer the call from Canton. The Super Bowl MVP in 2008 and 2012 was announced as a ...